InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (50 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
50
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Saxonov Serge, Chief Executive Officer. Director active across 1 company, notably 10x Genomics, Inc.. In total, 86 filings have been recorded. Split: 0 buy · 50 sells. Total volume traded: €5.9m. Activity tracked since 4 May 2021. The latest transaction was filed on 26 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Saxonov Serge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations86 total
3,500 shares@ US$63.0229Class A Common StockSEC:0001610717-26-000393:0
6,494 shares@ US$63.9768Class A Common StockSEC:0001610717-26-000393:1
492 shares@ US$64.7465Class A Common StockSEC:0001610717-26-000393:2
18,545 shares@ US$63.02370.014% mcap14.5% of flowClass A Common StockSEC:0001610717-26-000392:0
4,000 shares0Class A Common StockSEC:0001610717-26-000386:0
8,527 sharesClass A Common StockSEC:0001610717-26-000293:0
9,991 sharesClass A Common StockSEC:0001610717-26-000293:1
9,821 sharesClass A Common StockSEC:0001610717-26-000293:2
1,661 sharesClass A Common StockSEC:0001610717-26-000293:3
18,175 shares@ US$24.44150.0059% mcap8.4% of flowClass A Common StockSEC:0001610717-26-000164:0
10,718 shares@ US$24.70920.0035% mcap5.0% of flowClass A Common StockSEC:0001610717-26-000164:1
5,000 shares@ US$24.55680.0016% mcap2.2% of flowClass A Common StockSEC:0001610717-26-000145:0
10,000 shares@ US$19.12973.8% of flowClass A Common StockSEC:0001610717-26-000134:0
14,292 shares@ US$22.6695.6% of flowClass A Common StockSEC:0001610717-26-000086:0
157,895 shares0Class A Common StockSEC:0001610717-26-000077:0
9,632 shares@ US$18.57643.1% of flowClass A Common StockSEC:0001610717-26-000070:0
50,000 shares@ US$1.201.1% of flowClass A Common StockSEC:0001610717-26-000003:0
13,261 shares@ US$18.99834.8% of flowClass A Common StockSEC:0001610717-25-000398:0
900 shares0Class A Common StockSEC:0001610717-25-000341:0
9,348 shares@ US$13.7872.4% of flowClass A Common StockSEC:0001610717-25-000321:0
1,000 shares0Class A Common StockSEC:0001610717-25-000199:0
3,000 shares0Class A Common StockSEC:0001610717-25-000147:0
9,343 shares@ US$8.29931.5% of flowClass A Common StockSEC:0001610717-25-000144:0
171,428 shares0Class A Common StockSEC:0001610717-25-000075:0
7,942 shares@ US$10.62621.8% of flowClass A Common StockSEC:0001610717-25-000049:0
25 of 86 declarations
About Saxonov Serge
Saxonov Serge is Chief Executive Officer at 10x Genomics, Inc. He has made 81 filings in total, and the 81 sampled filings, from 2021-05-05 to 2026-06-24, show only sales for a total of EUR 4376621, with the modal transaction nature listed as Cession.
